Caption Management, LLC Evolus, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $671,935 - $884,768	-64,300 Reduced 36.49%	111,900 $1.21 Million
Q1 2024 May 15, 2024	BUY	$9.99 - $14.91 $1.73 Million - $2.58 Million	172,800 Added 5082.35%	176,200 $2.47 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $1.87 Million - $2.59 Million	-246,400 Reduced 98.64%	3,400 $35,000
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $1.79 Million - $2.55 Million	249,800 New	249,800 $2.28 Million
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $64,320 - $331,851	-20,100 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $842,712 - $1.4 Million	-288,600 Reduced 93.49%	20,100 $68,000
Q3 2020 Nov 16, 2020	BUY	$3.03 - $5.48 $825,978 - $1.49 Million	272,600 Added 755.12%	308,700 $1.21 Million
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $127,433 - $222,737	36,100 New	36,100 $192,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $609M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.